Joseph T. Morrissey Jr. - 27 Feb 2026 Form 4 Insider Report for Organon & Co. (OGN)

Role
Interim CEO
Signature
/s/ Faye C. Brown, as Attorney-in-Fact for Joseph T. Morrissey, Jr.
Issuer symbol
OGN
Transactions as of
27 Feb 2026
Net transactions value
-$73,769
Form type
4
Filing time
03 Mar 2026, 18:56:43 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrissey Joseph T. Jr. Interim CEO C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY /s/ Faye C. Brown, as Attorney-in-Fact for Joseph T. Morrissey, Jr. 03 Mar 2026 0001859805

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Award $0 +27,564 +39% $0.000000 99,126 27 Feb 2026 Direct F1
transaction OGN Common Stock Tax liability $57,747 -8,054 -8.1% $7.17 91,072 27 Feb 2026 Direct
transaction OGN Common Stock Award $0 +7,777 +8.5% $0.000000 98,849 27 Feb 2026 Direct F2
transaction OGN Common Stock Tax liability $16,022 -2,216 -2.2% $7.23 98,571 27 Feb 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2023 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
F2 Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
F3 Includes the addition of 1,938.068 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.